McMillen, 1995 - Google Patents
Characterization of the immune response to vaccination of racing greyhoundsMcMillen, 1995
- Document ID
- 116337727093533652
- Author
- McMillen G
- Publication year
External Links
Snippet
Parvoviral enteritis continues to cause financial losses for commercial greyhound kennel owners and, as a result, multiple vaccinations are administered to young dogs in an attempt to enhance disease protection. In order to evaluate greyhound vaccination protocols in a …
- 238000002255 vaccination 0 title abstract description 181
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ikemori et al. | Passive protection of neonatal calves against bovine coronavirus-induced diarrhea by administration of egg yolk or colostrum antibody powder | |
KR101099883B1 (en) | How to administer the vaccine | |
De Smit et al. | Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination | |
Saif et al. | Immunity to transmissible gastroenteritis virus and porcine respiratory coronavirus infections in swine | |
JP2655876B2 (en) | Canine Coronavirus Vaccine | |
Haesebrouck et al. | Effect of intratracheal challenge of fattening pigs previously immunised with an inactivated influenza H1N1 vaccine | |
KRUGER et al. | Glycoproteins gI and gE of Feline Herpesvirus-1 Are Virulence Genes: Safety and Efficacy of a gI–gE− Deletion Mutant in the Natural Host | |
Chandrasekaran et al. | Characterization of immune response and duration of protection in buffaloes immunized with haemorrhagic septicaemia vaccines | |
Oldham et al. | In vivo role of lymphocyte subpopulations in the control of virus excretion and mucosal antibody responses of cattle infected with rotavirus | |
Fairbanks et al. | Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge | |
WO2020104640A1 (en) | A vaccine for protection against streptococcus suis | |
US5916570A (en) | Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection | |
Hodgins et al. | Serologic responses of young colostrum fed dairy calves to antigens of Pasteurella haemolytica A1 | |
JPH08502253A (en) | Method for enhancing cell-mediated immune response | |
McMillen | Characterization of the immune response to vaccination of racing greyhounds | |
Erickson et al. | Comparative efficacy of modified-live and inactivated vaccines in boosting disease-sparing responses to bovine viral diarrhea virus challenge in neonatally mucosally primed weanling beef calves | |
JP2608935B2 (en) | Vaccines that protect cats against feline infectious peritonitis | |
Vanderpooten et al. | Evaluation of parenteral vaccination methods with glycoproteins against Aujeszky's disease in pigs | |
WO2021185680A1 (en) | A vaccine for protection against streptococcus suis serotype 9, sequence type 16 | |
Gough et al. | A viral subunit immunogen for porcine transmissible gastroenteritis | |
Odeón et al. | The role of cell-mediated immunity in the pathogenesis of bluetongue virus serotype 11 in the experimental infection of vaccine/sensitized calves | |
Tan et al. | Further studies on feline respiratory virus diseases: 1. Vaccination experiments | |
Poppensiek et al. | Twenty-five years of progress in understanding major infectious diseases of dairy cattle | |
Tan | Serological comparisons of feline respiratory viruses | |
Ortiz et al. | Suppression of the humoral immune response to inactivated Newcastle disease virus by Mycoplasma meleagridis in the Turkey |